Literature DB >> 29447374

Spectrum of Pediatric Tuberculosis in a Tertiary Care Setting in South India.

Betsy Rebecca1, Anila Chacko1, Valsan Verghese1, Winsley Rose1.   

Abstract

BACKGROUND: Pediatric tuberculosis (TB) is often underdiagnosed with poor estimate of its true burden. Availability of Xpert MTB/RIF assay enhances diagnostic capacity of pediatric TB.
METHODS: A 3-year retrospective review of hospital records was done for all children diagnosed with confirmed and unconfirmed TB. Comparison was made between intrathoracic, single-site extrathoracic and disseminated TB.
RESULTS: In total, 274 children had TB with 130 (47.4%) having confirmed TB. Pulmonary (23.4%), lymph node (23%) and central nervous system (12.8%) TB were the three commonest forms. HIV TB coinfection was 2.9%. Mycobacterial culture was positive in 90 (32.8%) and XPert MTB/RIF in 85 patients (31%). Mycobacterial confirmation was obtained in 45 (56.3%) intrathoracic TB, 69 (45.4%) extrathoracic TB and 16 (38.1%) disseminated TB. Correlation between positive Xpert and mycobacterial culture was poor (kappa 0.38). Rifampicin resistance was present in 25 (19.2%) of the 130 microbiologically confirmed TB.
CONCLUSION: Extrathoracic TB is common in children. Mycobacterial confirmation in pediatric TB is improved with use of Xpert.

Entities:  

Mesh:

Year:  2018        PMID: 29447374     DOI: 10.1093/tropej/fmy007

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  6 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 2.  Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.

Authors:  Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

3.  High Sensitivity C Reactive Protein: An Adjunct Diagnosis in Ruling Out Pediatric Tuberculosis.

Authors:  Bineeta Kashyap; Neha Gupta; Pooja Dewan; Puneeta Hyanki; N P Singh
Journal:  Indian J Clin Biochem       Date:  2019-01-01

4.  Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis.

Authors:  Hou-He Li; Zhi-Jian He; Jia-Qi Liang; Gui-Lin Li; Tian-Ao Xie; Ye-Ling Liu; Zhong-Wei Li; Xuan-Cheng Feng; Yong Xia; Xu-Guang Guo
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

Review 5.  Xpert MTB/RIF Assay for the Diagnosis of Lymph Node Tuberculosis in Children: A Systematic Review and Meta-Analysis.

Authors:  Hao-Kai Chen; Rui-Si Liu; Yi-Xuan Wang; En-Xiang Quan; Yuan-Hua Liu; Xu-Guang Guo
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

6.  Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.

Authors:  Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.